 The study includes the following steps: a initial assessment of participants psychopathology and symptom levels; b attention bias measurement; c 8 sessions of ABMTplacebo control delivered as part of the CBGT sessions; d two booster ABMTPlacebo treatments will be delivered at sessions 13 and 16 of the CBGT protocol. e post-treatment assessment will include symptom and attention bias assessments. Finally, f a three-month follow up assessment. 